Borderless Health, Making Quality Medical Care Within Reach
"Borderless Health · Quality Medical Care" — This is not only the brand original aspiration of Henan Leiden International Medical, but also the action guideline for our 17 years of deep cultivation in the cross-border medical field. We have never defined ourselves as an ordinary health consulting institution; instead, we take "breaking geographical barriers and integrating global high-quality medical resources" as our mission. We are committed to providing Chinese families with full-chain cross-border medical solutions ranging from preventive screening to severe disease diagnosis and treatment, and from personal health management to industry institution empowerment, allowing the dignity of life to cross national borders and high-quality medical care to benefit more people.
Since its establishment in 2008, Leyton International Medical has always focused on the core track of cross-border medical services, gradually evolving from initial overseas medical consultation services into a professional "trinity" platform integrating "International Medical Resource Integrator + Full-process Health Service Provider + Industry Empowerment Partner".
We adhere to the core proposition of "Cutting-edge Technology, Humanistic Care, and Inclusive Value", eliminate intermediate links, directly connect with high-quality global medical resources, thoroughly address users' pain points of "difficulty in accessing resources, communication barriers, and cumbersome processes", and contribute to the implementation of the "Healthy China 2030" Strategy.
Our team consists of internationally renowned medical experts, management consultants, and bilingual service elites. They not only have profound experience in the medical industry, but also can accurately connect advanced international medical concepts with domestic needs, committing to building a "professional bridge" to world-class medical care for medical institutions and individuals.
Our services cover areas such as International Cooperation Planning for Hospitals, International Medical Resource Connection, and Personal Precision Medical Services (Chronic Disease Management, Overseas Medical Checkup/Medical Treatment, International Second Medical Opinion, Regenerative Medicine), providing comprehensive solutions for medical institution upgrading and personal health management.
Our Service Process
Needs & Assessment
Customized Plan & Coordination
Diagnosis, Treatment & Follow-up
Development History
1981.3
Laying the Foundation of Swiss Medical Resources
Founded in Zurich by Dr. John Vanlimburg Stirum, Switzerland's SGK Medical Center (Seegarten Klinik) takes "Anti-Aging Science and Technology" as its core positioning. It pioneered the exploration of high-end preventive medical care and anti-aging fields in Switzerland, laying a professional foundation of over 30 years for subsequent cross-border cooperation.
2008.2
Establishment of Leyton Foreign Consulting Center, Focusing on Medical Consultation Initiation
Initially centered on "international consulting in the medical and health field", it provided basic management consulting services for domestic medical institutions, gradually accumulating medical industry resources and user demand insights, and building a localized service team.
2010.7
Strategic Cooperation with Japan's CBNB, Launching Japan Medical Resource Connection
Leyton became the sole strategic partner of Japan's CBNB Unshuku Co., Ltd. in China (CBNB holds official certification for medical services from Japan's Ministry of Foreign Affairs), achieving direct connection with high-end Japanese medical resources for the first time. During the same period, it initially partnered with the National Cancer Center Hospital and Sakakibara Heart Institute in Japan, launching the first generation of services including "Overseas Precision Medical Checkup in Japan" and "International Second Opinion", breaking down the Sino-Japanese medical information barrier.
2014.11
Compliance Layout of Japanese Regenerative Medicine, Business Dimension Expansion
With the official implementation of Japan's "Act on the Safety of Regenerative Medicine", Leyton simultaneously completed the connection of compliant regenerative medical services in Japan, focusing on the field of "Autologous Adipose-Derived Mesenchymal Stem Cell (ADMSC) Transplantation". It became one of the early platforms in China to carry out compliant regenerative medical services in Japan; in the same year, the number of domestic medical institutions served exceeded 100, and individual users exceeded 2,000.
2018.10
Strategic Cooperation with Switzerland's SGK and SCC, Building an International Medical Resource Matrix
Leyton established core strategic cooperative partnerships with Switzerland's SGK Medical Center and Swiss Central Hospital (SCC), introducing Switzerland's "Pharmacogenomic Anti-Aging" and "GMP-Compliant Day Surgery" resources into China for the first time. It launched the "China-Japan-Switzerland Three-Country Medical Service Package", realizing a full-cycle service closed loop of "Preventive Anti-Aging (Switzerland) + Critical Illness Diagnosis and Treatment (Japan) + Postoperative Rehabilitation (China)".
2022.3
Breakthrough in Large-Scale Services, Brand Influence Upgrade
The cumulative number of individual users served exceeded 10,000, among which the early tumor detection rate of users undergoing medical checkups in Japan reached 3.2% (typical case: Mr. Bai, 65 years old, was detected with early gastric adenocarcinoma through the service and received timely intervention), and the user satisfaction rate of Swiss anti-aging services exceeded 99%. It cooperated with more than 500 medical institutions and became the designated partner for "international medical cooperation" of hospitals in many regions. It established a "China-Japan-Switzerland Multilingual Service Team" (including over 100 medical translators and health consultants), and the full-process service response speed was upgraded to "demand connection within 1 hour and program output within 3 working days".
2024.7
Resource Deepening and Digital Upgrade, Iterating Full-Cycle Services
Japan End: Newly added "Remote Pre-Evaluation" service in cooperation with Medipolis Proton Therapy and Research Center, allowing domestic users to obtain preliminary proton therapy plans for cancer without going to Japan. Switzerland End: Jointly launched "Remote Anti-Aging Consultation" with SGK, remotely customizing anti-aging plans through pharmacogenomic reports.
Partial Cooperation Partners
Chinese 
English 
Japanese